| Trial ID: | L0147 |
| Source ID: | NCT00094484
|
| Associated Drug: |
Cinacalcet Hcl
|
| Title: |
Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Disease|Chronic Kidney Disease
|
| Interventions: |
DRUG: Cinacalcet HCl
|
| Outcome Measures: |
Primary: Proportion of subjects with a mean reduction of greater than or equal to 30% in iPTH at 32 weeks | Secondary: Changes in iPTH at 32 weeks.|Safety and tolerability of cinacalcet at 32 weeks.
|
| Sponsor/Collaborators: |
Sponsor: Amgen
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
400
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-10
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2013-05-08
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00094484
|
